The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: An immunohistochemical study

European Journal of Surgical Oncology

Volumn 27, Issue 6, 2001, Pages 527-531

  Morris, S F ^a   O'Hanlon, D M ^a   McLaughlin, R ^a   McHale, T ^a   Connolly, G E ^a   Given, H F ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Breast neoplasia; CD44; CD445; CD44v6; Prognosis

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN; MARKER;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TISSUE SECTION; TUMOR VOLUME;

EID: 0034853807     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2001.1167     Document Type: Article

References (32)

1. Homing receptors and the control of lymphocyte migration
2. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man
3. Leukocyte-endothelial cell adhesion as an active, multistep process: A combinatorial mechanism for specificity and diversity in leukocyte targeting
4. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family
5. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells
6. CD44
7. Normal human tissues in addition to some tumours express multiple different CD44 isoforms
8. Expression of CD44RI adhesion molecules in colon carcinomas and metastases
9. CD44 and cancer
10. Analysis of anomalous CD44 expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms
11. CD44 expression patterns in breast cancer and colon tumours: A PCR-based study of splice variants
12. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
13. The two major CD44 proteins expressed on metastatic rat rumour cell lines are derived from different splice variants; each individually suffices to confer metastatic behaviour
14. Prevention of tumour metastasis formation by anti-variant CD44
15. Significance of CD44 gene products for cancer diagnosis and disease evaluation
16. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer
17. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential
18. Soluble CD44 v5 and v6 variants in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumours and location of distant metastases
19. Soluble CD44 splice variants in metastasizing human breast cancer
20. CD44 variant exon epitopes in primary breast cancer and length of survival
21. Glycoprotein CD44 expression and its association with survival in breast cancer
22. Cytosol concentration of CD44 isoforms in breast cancer tissue
23. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6, and CD44v7-8 in human breast cancer
24. Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas
25. A CD44 variant exon 5 epitope as a prognostic indicator in breast cancer
26. CD44 variant isoform expression and breast cancer prognosis
27. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma
28. CD44 isoforms with exon v6 and metastasis of primary NOMO breast carcinomas
29. Prognostic value of CD44 variant expression in primary breast cancer
30. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression
31. CD44v6 is not a prognostic factor in primary breast cancer
32. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long term follow up